SBC Medical Group Holdings Incorporated (SBC) Stock Forecast & Price Target
SBC Medical Group Holdings Incorporated · NASDAQ
$3.19+0.14 (+4.41%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering SBC Medical Group Holdings Incorporated, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $8.00 to $8.00, so the covering firms are broadly aligned. The average target of $8.00 sits 150% above the current $3.19. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.12 next quarter toward $0.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to SBC Medical Group Holdings Incorporated.
As of Jul, 1 of 1 firms rate SBC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SBC EPS & revenue forecast
EPS · NEXT QUARTER
$0.12
Range $0.11 – $0.13 · 4 analysts · +0% YoY
Next period, 4 analysts expect SBC Medical Group Holdings Incorporated to earn $0.12 a share (range $0.11 – $0.13), versus $0.12 a year earlier. Full-year consensus is $0.47, growing to $0.48 the year after.
REVENUE · NEXT QUARTER
$46.0M
Range $42.5M – $47.8M · 4 analysts · +6% YoY
Revenue is expected to reach $46.0M (range $42.5M – $47.8M), +6.0% year-over-year. Full-year consensus is $181.0M, rising to $196.3M next year.
Top analysts covering SBC Medical Group Holdings Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SBC.
#1
SE
Sam Eiber
BTIG
Buy
$8.00+150.4% to target
Coverage
—
+ Follow
SBC stock forecast FAQ
What is SBC's average 12-month price target?+
The 1 analysts with a live target average $8.00 for SBC Medical Group Holdings Incorporated over the next 12 months, ranging from a $8.00 high to a $8.00 low.
Is SBC stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover SBC?+
1 analysts have an active rating on SBC Medical Group Holdings Incorporated, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering SBC?+
Among analysts who currently cover SBC, Sam Eiber of BTIG has the strongest overall Quantellect track record. Their current call is Buy with a $8.00 target.
What is SBC Medical Group Holdings Incorporated's projected EPS for next quarter?+
The consensus estimate is $0.12 per share (range $0.11 – $0.13) across 4 analysts. Full-year EPS is projected at $0.47, rising to $0.48 the following year.
How much revenue is SBC Medical Group Holdings Incorporated expected to report next quarter?+
Consensus revenue is $46.0M (range $42.5M – $47.8M). Full-year revenue is projected at $181.0M, growing to $196.3M next year.
Have analysts been upgrading or downgrading SBC lately?+
As of Jul, 1 of 1 firms rate SBC a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SBC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
